Jan. 25, 2007 - Cardinal Health said it will sell its pharmaceutical technologies and services businesses to the Blackstone Group, a private equity firm, for about $3.3 billion in cash. Cardinal announced plans to divest the business in November 2006 in order to focus its full attention and resources on its supply chain and clinical products businesses.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now